This trial is testing whether home High flow Nasal Therapy (HFNT) is better than usual COPD medical care for exacerbation prevention in moderate to very severe COPD patients.
1 Primary · 14 Secondary · Reporting Duration: 1 year
642 Total Participants · 2 Treatment Groups
Primary Treatment: Usual COPD care with use of the myAirvo 3 integrated humidifier and flow generator. · No Placebo Group · N/A
Age 18+ · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: